Q3 2025 Earnings Call Transcript August 6, 2025 Cencora, Inc. beats earnings expectations. Reported EPS is $4, expectations were $3.85. Operator: Hello, everyone, and thank you for joining the Cencora ...

Cencora (COR) recently announced strong third-quarter earnings with sales at $80,664 million and net income rising to $687 million, reflecting significant growth. Despite these robust results, the ...

U.S. drug distributor Cencora raised its annual profit forecast on Wednesday after posting quarterly earnings that topped Wall Street estimates, buoyed by surging demand for specialty therapies and ...

Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the ...

COR benefits from strong specialty and GLP-1 demand, but Q3 results may face pressure from international weakness.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Shares of Cencora Inc. COR shed 2.93% to $283.78 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.73% to 6,345.06 and ...

CONSHOHOCKEN, Pa. - On Wednesday, Cencora, Inc. (NYSE: COR) reported third-quarter fiscal 2025 results that exceeded analyst expectations, with adjusted earnings per share of $4.00 beating the ...

Texas-headquartered Mckesson expects per-share profit in the range of $37.10 to $37.90 for fiscal 2026, compared to its ...

Cencora, Inc. ( NYSE: COR) Q3 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Bennett S. Murphy - Senior VP, Head of Investor Relations & Treasury James F. Cleary - Executive VP & CFO Robert P ...

Shares of Cencora Inc. COR slipped 1.96% to $286.08 Thursday, on what proved to be an all-around rough trading session for ...